Genzyme beats Street

GENZ reported second quarter 2005 non-GAAP EPS of $0.57, beating the Street estimate by $0.04 and up 30% from $0.44 in the second quarter

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE